Tag: novartis

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Oral remibrutinib hits Phase 3 primary endpoint for inducible hives

byDeepti Shroff

March 5, 2026

1. Oral remibrutinib successfully met its primary endpoint in the Phase III RemIND trial, delivering significant symptom relief for chronic ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
Looksmaxxing raises body dysmorphia concerns among adolescent males
A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

No Result

View All Result

Tag: novartis

Oral remibrutinib hits Phase 3 primary endpoint for inducible hives

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits